A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...

A new AI system from Mayo Clinic finds signs of the most common form of pancreatic cancer much earlier than standard ...

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

I’ve been poring over the news around Intellia Therapeutics’ NTLA-2001, an in vivo CRISPR-Cas9 therapy to inactivate the TTR gene in two sets of transthyretin amyloidosis patients. On October 27, 2025 ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.